Calithera Biosciences Inc (CALA.OQ)
CALA.OQ on NASDAQ Stock Exchange Global Select Market
6.02USD
23 Apr 2019
6.02USD
23 Apr 2019
Change (% chg)
$-0.01 (-0.17%)
$-0.01 (-0.17%)
Prev Close
$6.03
$6.03
Open
$6.04
$6.04
Day's High
$6.25
$6.25
Day's Low
$6.02
$6.02
Volume
1,793
1,793
Avg. Vol
51,248
51,248
52-wk High
$6.90
$6.90
52-wk Low
$3.55
$3.55
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Dec '18 | 0.00 | -0.508 |
| Sep '18 | 0.00 | -0.518 | |
| Jun '18 | 17.07 | -0.086 | |
| Mar '18 | 5.19 | -0.369 | |
| FY 2017 | Dec '17 | 7.25 | -0.308 |
| Sep '17 | 7.25 | -0.171 | |
| Jun '17 | 7.26 | -0.147 | |
| Mar '17 | 4.19 | -0.221 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-19 | 3 | 4.33 | 7.00 | 0.00 | 3.00 |
| Quarter Ending Sep-19 | 3 | 4.33 | 7.00 | 0.00 | 3.00 |
| Year Ending Dec-19 | 3 | 17.33 | 28.00 | 0.00 | 20.99 |
| Year Ending Dec-20 | 3 | 17.10 | 28.00 | 0.00 | 86.20 |
| Earnings (per share) | |||||
| Quarter Ending Jun-19 | 4 | -0.46 | -0.37 | -0.56 | -0.42 |
| Quarter Ending Sep-19 | 4 | -0.46 | -0.37 | -0.61 | -0.44 |
| Year Ending Dec-19 | 4 | -1.82 | -1.48 | -2.36 | -1.88 |
| Year Ending Dec-20 | 4 | -1.66 | -1.31 | -2.40 | -1.77 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 110.59 | 62.94 | |
| P/E High - Last 5 Yrs. | -- | 162.88 | 56.44 | |
| P/E Low - Last 5 Yrs. | -- | 52.22 | 28.76 | |
| Beta | 2.25 | 1.17 | 0.93 | |
| Price to Sales (TTM) | 10.61 | 45.83 | 9.69 | |
| Price to Book (MRQ) | 1.85 | 13.27 | 4.53 | |
| Price to Tangible Book (MRQ) | 1.86 | 18.94 | 8.07 | |
| Price to Cash Flow (TTM) | -- | 73.77 | 43.55 | |
| % Owned Institutions | -- | 0.00 | 0.00 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 0.09 | 1.54 | |
| Dividend Yield - 5 Year Avg | -- | 0.05 | 0.70 | |
| Dividend 5 Year Growth Rate | -- | 0.71 | 2.98 | |
| Payout Ratio(TTM) | -- | 8.47 | 21.89 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -100.00 | 22.25 | 9.11 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -14.26 | 66.82 | 8.34 | |
| Sales - 5 Yr. Growth Rate | -- | 33.24 | 11.19 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | -64.88 | -90.31 | 112.52 | |
| EPS (TTM) vs TTM 1 Yr. Ago | -74.76 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 21.66 | 6.94 | |
| Capital Spending - 5 Yr. Growth Rate | 5.47 | 25.54 | 7.63 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 2.81 | 2.67 |
| Current Ratio (MRQ) | 9.42 | 3.64 | 3.63 |
| LT Debt to Equity (MRQ) | 0.00 | 7.02 | 13.38 |
| Total Debt to Equity (MRQ) | 0.00 | 20.04 | 17.12 |
| Interest Coverage (TTM) | -- | 11.13 | 27.35 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 25.49 | 50.33 | |
| Gross Margin - 5 Yr. Avg. | -- | 60.05 | 50.77 | |
| EBITD Margin (TTM) | -255.13 | -- | -- | |
| EBITD - 5 Yr. Avg | -369.04 | -10.78 | 15.75 | |
| Operating Margin (TTM) | -257.40 | -108.32 | -2.12 | |
| Operating Margin - 5 Yr. Avg. | -373.04 | -26.36 | 11.07 | |
| Pre-Tax Margin (TTM) | -245.48 | -109.04 | -2.97 | |
| Pre-Tax Margin - 5 Yr. Avg. | -362.62 | -29.08 | 16.81 | |
| Net Profit Margin (TTM) | -245.48 | -115.42 | -6.92 | |
| Net Profit Margin - 5 Yr. Avg. | -362.62 | -34.27 | 11.75 | |
| Effective Tax Rate (TTM) | -- | 19.94 | 22.89 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 19.62 | 23.86 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 281,696 | 8,473,856 | 767,389,378 | |
| Net Income/Employee (TTM) | -691,506 | 1,875,927 | 88,365,779 | |
| Receivable Turnover (TTM) | 14.18 | 2.36 | 5.22 | |
| Inventory Turnover (TTM) | -- | 2.32 | 3.64 | |
| Asset Turnover (TTM) | 0.13 | 0.32 | 0.80 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -32.60 | 6.37 | 9.51 | |
| Return on Assets - 5 Yr. Avg. | -33.84 | 6.26 | 10.45 | |
| Return on Investment (TTM) | -38.84 | 8.01 | 11.75 | |
| Return on Investment - 5 Yr. Avg. | -38.25 | 8.20 | 13.34 | |
| Return on Equity (TTM) | -39.44 | 8.19 | 12.58 | |
| Return on Equity - 5 Yr. Avg. | -41.10 | 9.32 | 14.82 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -14.26 | -- | -- |
| EPS (TTM) % | -76.73 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Calithera Biosciences Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | -5.49 | -9.05 | 76 | 91 |
| 13 Week | 35.20 | 24.17 | 99 | 82 |
| 26 Week | 15.74 | 9.69 | 99 | 9 |
| 52 Week | -1.15 | -9.23 | 99 | 27 |
| YTD | 50.37 | 29.63 | 99 | 28 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 67.81% |
| # of Holders: | 112 |
| Total Shares Held: | 26,551,533 |
| 3 Mo. Net Change: | -28,506 |
| # New Positions: | 0 |
| # Closed Positions: | 4 |
| # Increased Positions: | 3 |
| # Reduced Positions: | 10 |
| # Net Buyers: | -7 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.